U.S. Online Retail and Ecommerce Stock News

TopBuild (BLD) posted a net profit margin of 10.8%, down from 11.7% the previous year, while the company’s earnings have grown at an annualized rate of 18% over the past five years. However, recent momentum has slowed, with negative earnings growth reported for the most recent period, and forward-looking expectations point to just 2.5% annual earnings growth and 9.9% revenue growth, both trailing behind US market averages. The stock trades at a price-to-earnings ratio of 20.6x, which is a...

Stanley Black & Decker (SWK) just turned the corner on profitability after years of declining earnings, reporting a projected earnings growth rate of 30.2% per year that outpaces both its industry and the broader US market. Revenue, however, is forecast to grow at a slower clip of 3.9% per year, trailing the US market’s expected 10.5% gain. The company’s return to profitability comes after a notable one-off loss of $525.6 million over the last twelve months, putting renewed focus on the...

Nuvation Bio (NUVB) posted another year of widening losses, with its net income declining at an average annual rate of 45.2% over the past five years. Still, analysts expect revenue to surge by 51.23% per year, outpacing the broader US market’s average growth of 10.5%. Despite the robust outlook, shares currently trade at $4.83, well below the company’s estimated fair value of $19.43 based on a discounted cash flow model. Profitability remains elusive and margins show no signs of meaningful...

Gaia (GAIA) remains in the red, recording unprofitable results with net losses worsening at an average annual rate of 48.7% over the past five years. Despite the ongoing losses, forecasts now point to rapid improvement, with earnings expected to grow by 95.93% per year and a return to profitability within three years. This would outpace most of the market. Meanwhile, revenue growth is set to reach 14.1% annually, which exceeds the predicted 10.5% average across the US market. At a trading...

Verastem (VSTM) is on track for standout top-line growth, with revenue forecast to surge 55.7% per year, well ahead of the broader US market’s 10.5% pace. Despite this bullish revenue outlook, the company remains unprofitable and is projected to stay in the red for at least the next three years, as losses have risen by 23.7% per year over the past five years without net margin improvement. Investor focus this quarter will be on whether Verastem can turn strong growth potential into a path...

Centerspace (CSR) is forecasting a steep annual earnings decline of 36.6% over the next three years, even as revenue is expected to grow modestly at 2.2% per year, trailing the broader US market’s 10.5% pace. While the company has recently turned profitable, reported net profits were boosted by a one-off gain of $52.9 million. Its average annual earnings have fallen by 16% over the past five years. With growth rates lagging and profit quality impacted by non-recurring items, investors may...

IDEAYA Biosciences (IDYA) reported a 45.2% per year increase in losses over the past five years and is forecasted to remain unprofitable for at least the next three years. However, revenue is projected to grow at 28.3% per year, notably outpacing the US market average of 10.5%. With robust top-line growth but continuing net losses, the results reflect a company in high-growth mode with persistent profitability hurdles for investors to watch. See our full analysis for IDEAYA Biosciences. Next,...

Integral Ad Science Holding (IAS) posted current net profit margins of 7.9%, improving from 6.4% a year ago, while earnings grew 42.9% over the last twelve months. This is an impressive figure, though it remains below the robust five-year average growth rate of 73.5% per year. Looking ahead, analysts project revenue to rise at 10.1% per year and forecast significant earnings growth at 23.1% per year, both pointing to momentum outpacing much of the US market. With margins expanding and growth...

Neuronetics (STIM) is currently unprofitable, with annual losses widening by 10.3% on average over the past five years. Despite no improvement in net profit margin and the expectation that the company will remain unprofitable for at least the next three years, revenue is forecast to climb 12.1% a year, outpacing the broader US market’s 10.5% growth rate. Investors are likely to weigh the company’s above-average growth prospects and relatively attractive price-to-sales ratio of 1.5x against...

Life Time Group Holdings (LTH) posted robust earnings momentum, with net profit surging 101.6% year-over-year and profit margins improving to 9.9% from 5.7% the previous year. Investors saw earnings climb 73.2% per year on average over the past five years, while forecasts call for continued double-digit growth. For investors, the company’s steady profit expansion, improving margins, and appealing relative valuation set a strong tone for this earnings cycle. See our full analysis for Life Time...

Bancorp 34 (BCTF) recently returned to profitability, reversing its net profit margin compared to the prior period. Despite this progress, earnings have declined by 7.4% per year on average over the past five years. Its price-to-earnings ratio of 15.6x remains higher than both the US Banks industry average of 11x and the peer average of 11.6x. While the company is recognized for high quality earnings, the higher valuation multiples and lingering risks around future growth may weigh on...

Anywhere Real Estate (HOUS) is currently unprofitable, with losses over the past five years growing at an annual rate of 18.2%. Shares are trading at $10.98, below the estimated fair value of $16.31 based on discounted cash flow analysis. Earnings are forecast to rebound sharply, with 128.7% annual EPS growth expected, and the company is projected to return to profitability within three years. However, revenue is only forecast to rise by 8.4% per year, which trails the broader US market’s...

Solaris Energy Infrastructure (SEI) delivered a jump in net profit margin to 6.7% from last year’s 4.5%, riding a powerful 185.3% annual earnings growth that leaves its five-year average of 51.1% behind. Forecasts point to revenue growing 22.1% per year and an earnings climb of 41.4% per year, both well ahead of the broader US market pace. In this context of robust profitability, investors have to weigh a below-fair-value share price of $53.71 versus a discounted cash flow estimate of...

SNDL (NasdaqCM:SNDL) narrowed its losses by an average of 16.4% per year over the last five years, with forecasts now calling for explosive 168.19% annual earnings growth and a move to profitability within three years. While revenue is anticipated to grow just 2.8% per year, lagging the US market’s 10.5% rate, shares have remained volatile in recent months and stability is still elusive. Investors are weighing this rapid progress on the earnings front and SNDL’s discounted Price-to-Sales...

Great Lakes Dredge & Dock (GLDD) delivered a standout earnings result, posting a 36.3% increase in earnings over the past year, well ahead of its five-year average growth of 4.1% per year. The company’s net profit margin improved to 9.7%, up from 8% previously. This signals stronger profitability and efficiency even as the stock trades at $12.77, a premium relative to one benchmark of fair value. With high-quality earnings and a steady track record of growing profit or revenue, GLDD’s results...

Vitesse Energy (VTS) reported a net profit margin of 8.4%, well below last year’s 19.8%, as the company’s most recent period saw negative earnings growth despite averaging 24.1% annual earnings growth over the past five years. Looking ahead, revenue is projected to grow at just 0.9% per year, lagging the wider US market’s 10.5% average, and earnings are expected to drop sharply by 68.5% per year over the next three years. With shrinking margins and a premium 38.6x price-to-earnings ratio, the...

AC Immune (ACIU) remains unprofitable, with its net profit margin still negative. The company has narrowed its losses by an average of 5.9% annually over the past five years. Looking ahead, earnings are forecast to jump 66.51% per year and consensus expects profitability within three years. Revenue is set to rise 55.6% per year, outpacing the broader US market's projected growth of 10.5%. Despite a higher price-to-book ratio of 4.2x compared to the US Biotech industry's 2.5x, ACIU shares are...

HealthStream (HSTM) reported net profit margins of 6.9%, ticking up from last year’s 6.8%. Earnings have grown at an average annual rate of 18% over the last five years, but most recent annual earnings growth was 5%, coming in below that longer-term pace. Revenue is forecast to rise 4.7% per year and earnings at 7.7%, both trailing expectations for the wider US market. Valuation metrics present a mixed picture with the share price trading below one fair value estimate and a P/E lower than its...

Emergent BioSolutions recently reported third-quarter 2025 results, with revenue of US$231.1 million and net income of US$51.2 million, and raised its full-year 2025 guidance for both revenue and net income. The company's stronger-than-expected performance was supported by growth in NARCAN nasal spray, new U.S. government and international contracts, and a completed share repurchase program. We'll now examine how the company's upgraded full-year outlook and growth in core product lines may...

Safety Insurance Group (SAFT) posted a net profit margin of 7.1%, edging ahead of last year’s 6.8%, with EPS showing 16.7% growth for the year. This upbeat result comes despite a longer-term backdrop where average annual earnings have dropped 22.2% over five years. For investors, high-quality earnings, positive profitability trends, and an attractive dividend balance out concerns around continued long-term earnings declines and shares currently trading at $70.37, above fair value...

Tactile Systems Technology (TCMD) posted a net profit margin of 5.8%, edging above last year’s 5.4% and capping five years of earnings growing at a brisk 42.6% annual clip. Looking ahead, analysts expect earnings to climb a further 12.26% per year with revenue growth forecast at 8.9% per year, which is slower than the US market’s 10.5% projection. The setup combines an above-average valuation, a solid record of profitability, and margins that continue to climb. This sets the stage for...

Comstock Resources (CRK) turned profitable over the past five years, boasting average annual earnings growth of 8.6% and posting net profit margins finally in positive territory. Wall Street is sizing up this momentum, with forecasts calling for a massive 74.6% annual earnings growth, which easily outpaces the US market’s expected 16%. Revenue, meanwhile, is projected to rise at 9.8% per year, just a touch behind the US average of 10.5%. See our full analysis for Comstock Resources. Next, we...

SOPHiA GENETICS (NasdaqGS:SOPH) is forecast to post annual revenue growth of 17.91%, surpassing the broader US market's expected 10.5% rate. The company has not yet achieved profitability and losses have actually grown at 4% per year for the past five years, with its net profit margin still in negative territory. For investors, the critical narrative is clear: the top-line growth potential stands out, but persistent losses and questions around the path to profitability remain a defining...

Greenlight Capital Re (GLRE) remains unprofitable, but the company has narrowed its losses over the last five years at an annual rate of 25.2%. Despite the ongoing challenges to net profit margin, the stock is drawing investor attention thanks to a low Price-To-Sales Ratio of 0.6x versus a peer average of 4.9x and a trading price of $11.95, well below an estimated fair value of $20.06. With risk sentiment steady and no major negative headlines, the current results put the spotlight on...